Aspen Aerogels Statistics
Total Valuation
Aspen Aerogels has a market cap or net worth of $371.58 million. The enterprise value is $341.66 million.
Important Dates
The last earnings date was Thursday, November 5, 2026, before market open.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Aspen Aerogels has 83.13 million shares outstanding. The number of shares has increased by 1.16% in one year.
| Current Share Class | 83.13M |
| Shares Outstanding | 83.13M |
| Shares Change (YoY) | +1.16% |
| Shares Change (QoQ) | +0.21% |
| Owned by Insiders (%) | 1.27% |
| Owned by Institutions (%) | 74.16% |
| Float | 69.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.72 |
| Forward PS | 1.34 |
| PB Ratio | 2.19 |
| P/TBV Ratio | 2.00 |
| P/FCF Ratio | 18.50 |
| P/OCF Ratio | 12.17 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.58 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 17.00 |
Financial Position
The company has a current ratio of 2.10, with a Debt / Equity ratio of 0.63.
| Current Ratio | 2.10 |
| Quick Ratio | 1.71 |
| Debt / Equity | 0.63 |
| Debt / EBITDA | n/a |
| Debt / FCF | 5.82 |
| Interest Coverage | -4.21 |
Financial Efficiency
Return on equity (ROE) is -53.16% and return on invested capital (ROIC) is -29.74%.
| Return on Equity (ROE) | -53.16% |
| Return on Assets (ROA) | -6.72% |
| Return on Invested Capital (ROIC) | -29.74% |
| Return on Capital Employed (ROCE) | -17.50% |
| Weighted Average Cost of Capital (WACC) | 17.95% |
| Revenue Per Employee | $250,878 |
| Profits Per Employee | -$152,561 |
| Employee Count | 854 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 4.60 |
Taxes
In the past 12 months, Aspen Aerogels has paid $870,000 in taxes.
| Income Tax | 870,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +45.13% in the last 52 weeks. The beta is 3.08, so Aspen Aerogels's price volatility has been higher than the market average.
| Beta (5Y) | 3.08 |
| 52-Week Price Change | +45.13% |
| 50-Day Moving Average | 5.33 |
| 200-Day Moving Average | 4.81 |
| Relative Strength Index (RSI) | 39.36 |
| Average Volume (20 Days) | 1,392,490 |
Short Selling Information
The latest short interest is 6.41 million, so 7.71% of the outstanding shares have been sold short.
| Short Interest | 6.41M |
| Short Previous Month | 6.10M |
| Short % of Shares Out | 7.71% |
| Short % of Float | 9.19% |
| Short Ratio (days to cover) | 7.34 |
Income Statement
In the last 12 months, Aspen Aerogels had revenue of $214.25 million and -$130.29 million in losses. Loss per share was -$1.57.
| Revenue | 214.25M |
| Gross Profit | 47.75M |
| Operating Income | -47.64M |
| Pretax Income | -129.42M |
| Net Income | -130.29M |
| EBITDA | -27.03M |
| EBIT | -47.64M |
| Loss Per Share | -$1.57 |
Full Income Statement Balance Sheet
The company has $145.99 million in cash and $116.07 million in debt, with a net cash position of $29.92 million or $0.36 per share.
| Cash & Cash Equivalents | 145.99M |
| Total Debt | 116.07M |
| Net Cash | 29.92M |
| Net Cash Per Share | $0.36 |
| Equity (Book Value) | 184.44M |
| Book Value Per Share | 2.22 |
| Working Capital | 134.67M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $30.33 million and capital expenditures -$10.38 million, giving a free cash flow of $19.95 million.
| Operating Cash Flow | 30.33M |
| Capital Expenditures | -10.38M |
| Depreciation & Amortization | 20.61M |
| Net Borrowing | -36.09M |
| Free Cash Flow | 19.95M |
| FCF Per Share | $0.24 |
Full Cash Flow Statement Margins
Gross margin is 22.28%, with operating and profit margins of -22.23% and -60.81%.
| Gross Margin | 22.28% |
| Operating Margin | -22.23% |
| Pretax Margin | -60.40% |
| Profit Margin | -60.81% |
| EBITDA Margin | -12.61% |
| EBIT Margin | -22.23% |
| FCF Margin | 9.31% |
Dividends & Yields
Aspen Aerogels does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.16% |
| Shareholder Yield | -1.16% |
| Earnings Yield | -35.18% |
| FCF Yield | 5.40% |
Analyst Forecast
The average price target for Aspen Aerogels is $7.75, which is 73.38% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.75 |
| Price Target Difference | 73.38% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 16.26% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Aspen Aerogels has an Altman Z-Score of -2.27 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.27 |
| Piotroski F-Score | 3 |